(Q37894668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Richard J Cote

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

849-852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707281%20AND%20SRC:MED&resulttype=core&format=json

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

6 February 2020

cites work

1 reference

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base

21 January 2018

1 reference

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

21 January 2018

1 reference

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).

21 January 2018

1 reference

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

21 January 2018

1 reference

Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.

21 January 2018

1 reference

The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer

21 January 2018

1 reference

Expression profiling for bladder cancer: strategies to uncover prognostic factors.

21 January 2018

1 reference

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

21 January 2018

1 reference

Molecular pathogenesis and diagnostics of bladder cancer

21 January 2018

1 reference

Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays

21 January 2018

1 reference

Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays

21 January 2018

1 reference

Generation of a concise gene panel for outcome prediction in urinary bladder cancer

21 January 2018

1 reference

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles

21 January 2018

1 reference

Strategies for molecular expression profiling in bladder cancer.

21 January 2018

1 reference